Clinical Trials Directory

Trials / Completed

CompletedNCT02113839

Dyspnea in COPD: Relationship With Exacerbations Frequency

Breathlessness Perception in COPD: Relationship With Exacerbation Frequency

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Hospital Clinic of Barcelona · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The perception of breathlessness varies significantly among COPD patients with similar severity of airflow limitation; those with poorer perception report less exacerbations as compared to those with frequent exacerbations. Cross-sectional comparison of breathlessness perception in COPD patients with frequent exacerbations or without frequent exacerbations. To assess "Breathlessness Perception" the investigators will increase the ventilatory demand of the patients by CO2-rebreathing method.

Detailed description

The perception of breathlessness varies between individuals. This is a well-established concept in asthma, but mostly unexplored in COPD; the relationship between airflow limitation (FEV1, % ref.) and breathlessness (mMRC) is weak. The perception of breathlessness varies significantly among COPD patients with similar severity of airflow limitation; those with poorer perception report less exacerbations as compared to those with frequent exacerbations. It is a cross-sectional comparison of breathlessness perception in COPD patients with frequent exacerbations (≥2 or ≥1 with hospitalization in the previous year) or without frequent exacerbations (0 or 1 without hospitalization in the previous year). To assess "Breathlessness Perception" the investigators will increase the ventilatory demand of the patients by CO2-rebreathing method. CO2 rebreathing test will be conducted to evaluate the acute ventilatory response to CO2 inhalation used to estimate central chemoreceptor responsiveness in patients with the obstructive pulmonary disease. Simple descriptive statistics (unpaired T-test) and correlation analysis (bivariate and multivariate) will be used to analyze results.

Conditions

Interventions

TypeNameDescription
PROCEDURESpirometryBefore re-breathing (if the patient not performed one 6 months in advance).
PROCEDURECO Exhaled breathIn current smokers of both arms to confirm that the patient has not smoked in the past three hours and to asses the smoking status (heavy, moderate, light).
PROCEDUREP01P01 is the negative airway pressure generated during the first 100 ms of an occluded inspiration. It's an estimation of the neuromuscular drive to breathe.
PROCEDUREFeNOThe measurement of fraction of exhaled nitric oxide during exacerbations of COPD is higher than normal.

Timeline

Start date
2014-04-01
Primary completion
2014-08-01
Completion
2015-05-01
First posted
2014-04-15
Last updated
2015-08-20

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02113839. Inclusion in this directory is not an endorsement.